Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» multiple sclerosis
multiple sclerosis
Biogen's Tecfidera faces outside pressure
BioPharma Dive
Thu, 12/1/16 - 04:29 pm
Biogen
Tecfidera
multiple sclerosis
MS
patents
Forward Pharma
On the ropes, Opexa shares blasted by PhIIb multiple sclerosis trial flop
Endpoints
Fri, 10/28/16 - 10:08 am
Opexa
multiple sclerosis
MS
clinical trials
Tcelna
Novartis' Is Challenging Biogen on Biogen's Own Turf
Motley Fool
Wed, 10/26/16 - 09:19 pm
Novartis
Biogen
Gilenya
Tecfidera
MS
multiple sclerosis
If Roche's Ocrevus is approved, the already competitive MS market will gain another player
Medical Marketing and Media
Mon, 10/24/16 - 11:54 pm
Roche
Ocrevus
MS
multiple sclerosis
Insurers pay more for multiple sclerosis drug because rebates don’t help, report says
Stat/Pharmalot
Fri, 10/14/16 - 11:29 am
insurers
multiple sclerosis
MS
rebates
Novartis' Multiple Sclerosis Life Cycle Looks More Assured
Seeking Alpha
Tue, 09/20/16 - 09:48 am
Novartis
siponimod
MS
multiple sclerosis
As Tecfidera lags, Biogen hopes real-world data can help keep patients on their meds
Fierce Pharma
Mon, 09/19/16 - 09:54 am
Biogen
Tecfidera
MS
multiple sclerosis
Novartis shows a hole card in a high-stakes PhIII poker game for MS drugs
Endpoints
Sat, 09/17/16 - 01:23 pm
Novartis
MS
multiple sclerosis
siponimod
Roche’s megablockbuster MS candidate ocrelizumab posts promising head-to-head data
Endpoints
Wed, 09/14/16 - 11:42 pm
Roche
MS
multiple sclerosis
ocrelizumab
Biogen reports positive new data for multiple sclerosis treatment
Marketwatch
Wed, 09/14/16 - 09:13 am
Biogen
MS
multiple sclerosis
Tecfidera
Will MS Franchise & New Drugs Come To Biogen Rescue?
Bidness, ETC
Wed, 09/7/16 - 08:10 pm
Biogen
MS
multiple sclerosis
Nusinersen
SMA
aducanumab
Alzheimer's disease
Third U.S. patent on Teva's MS drug Copaxone invalidated
Reuters
Fri, 09/2/16 - 11:29 am
Teva Pharmaceutical
Copaxone
MS
multiple sclerosis
patents
Novartis AG MS Drug Yields Unexpected Positive: Big WIn?
Bidness, ETC
Sat, 08/27/16 - 09:47 am
Novartis
MS
multiple sclerosis
progressive MS
BAF312
Novartis scores a win in progressive MS
BioPharma Dive
Fri, 08/26/16 - 10:05 am
Novartis
progressive MS
MS
multiple sclerosis
BAF312
Generics creep in as Teva loses two Copaxone patents
BioPharma Dive
Fri, 08/26/16 - 09:55 am
Teva Pharmaceutical
Copaxone
patents
MS
multiple sclerosis
generics
Glatopa
Novartis
Sandoz
Why Momenta Pharmaceuticals Shares Made a Late-Day Jump Higher
Motley Fool
Wed, 08/24/16 - 05:40 pm
Momenta Pharmaceuticals
Teva Pharmaceutical
Copaxone
patents
Mylan Labs
multiple sclerosis
MS
Biogen Inc MS Drugs: Deadly Cash Cows?
Bidness, ETC
Fri, 08/5/16 - 11:28 am
Biogen
MS
multiple sclerosis
Tecfidera
Avonex
Tysabri
Plegridy
Biogen ends Tecfidera campaign, citing prescriptions
Medical Marketing and Media
Thu, 07/21/16 - 09:09 pm
Biogen
Tecfidera
drug ads
MS
multiple sclerosis
Biogen, AbbVie: How Significant is the New MS Drug Zinbryta
Bidness, ETC
Wed, 07/6/16 - 10:54 am
Biogen
AbbVie
Zinbryta
MS
multiple sclerosis
Helius touts 6-patient study of advanced MS cases
Mass Device
Sat, 06/25/16 - 01:36 pm
Helius
MS
multiple sclerosis
PoNS
devices
Pages
« first
‹ previous
…
8
9
10
11
12
13
14
15
16
…
next ›
last »